Doug is a seasoned, global digital business leader with a diverse background working with some of largest, most respected organizations in the world to transform operations and embrace next-generation collaboration to deliver transformative operational improvements.

Blending his intimate knowledge of regulatory (FINRA, NAIC, FDA, HIPAA) and information security considerations with his broad insight of the vendor/solution landscape, he specializes in developing a deep appreciation for the unique business challenges of an organization, then aligning appropriate solutions while also driving the change management necessary to realize the full potential of those solutions.

A recognized thought-leader, speaking at several vendor and industry conferences on best-practices for cultivating sustainable digital business transformation through cross-functional engagement, organizational alignment and the execution of a multi-year roadmap.

With more than 6,000 scientists, physicians and business professionals around the world, we have an open, entrepreneurial and innovative culture that encourages collaboration as we work to push the boundaries of science to change the practice of medicine. NIBR focuses on the following disease areas: • Autoimmunity, Transplantation, and Inflammatory Disease • Cardiovascular & Metabolic Diseases • Immuno-oncology • Infectious Diseases • Musculoskeletal Diseases • Neuroscience • Oncology • Ophthalmology • Respiratory Diseases NIBR has built expertise around several key technology competencies. Each competency combines automation and robotics, computational science, biology and irreplaceable drug discovery knowledge. By building expertise around key technologies, it can be more effectively applied across diseases that share similar mechanisms.